Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prevention of Bacteremia Induced by Debridement of Pressure Ulcer
This study has been terminated.
Sponsored by: Herzog Hospital
Information provided by: Herzog Hospital
ClinicalTrials.gov Identifier: NCT00269100
  Purpose

The purpose of this study is to analyse bacteremia induced by debridement of pressure ulcers in patients in the complex nursing department.


Condition Phase
Pressure Ulcers
Bacteremia
Phase I
Phase II

MedlinePlus related topics: Pressure Sores
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Prospective Study

Further study details as provided by Herzog Hospital:

Estimated Enrollment: 60
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient in the complex nursing department
  • With contaminated pressure ulcers
  • Going to have a debridement procedure

Exclusion Criteria:

  • Penicillin sensitivity
  • Bacteremia that does not react to the antibiotic treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00269100

Locations
Israel
Herzog Hospital
Jerusalem, Israel, 91351
Sponsors and Collaborators
Herzog Hospital
Investigators
Study Director: Efraim Jaul Herzog Hospital
  More Information

Study ID Numbers: Jaul1CTIL
Study First Received: December 22, 2005
Last Updated: April 19, 2007
ClinicalTrials.gov Identifier: NCT00269100  
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Herzog Hospital:
Debridement

Study placed in the following topic categories:
Systemic Inflammatory Response Syndrome
Bacterial Infections
Sepsis
Skin Diseases
Ulcer
Bacteremia
Skin Ulcer
Pressure Ulcer
Inflammation

Additional relevant MeSH terms:
Pathologic Processes
Infection

ClinicalTrials.gov processed this record on January 16, 2009